Comprehensive proteomic quantification of bladder stone progression in a cystinuric mouse model using data-independent acquisitions.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 26 03 2021
accepted: 03 06 2022
entrez: 30 6 2022
pubmed: 1 7 2022
medline: 6 7 2022
Statut: epublish

Résumé

Cystinuria is one of various disorders that cause biomineralization in the urinary system, including bladder stone formation in humans. It is most prevalent in children and adolescents and more aggressive in males. There is no cure, and only limited disease management techniques help to solubilize the stones. Recurrence, even after treatment, occurs frequently. Other than a buildup of cystine, little is known about factors involved in the formation, expansion, and recurrence of these stones. This study sought to define the growth of bladder stones, guided by micro-computed tomography imaging, and to profile dynamic stone proteome changes in a cystinuria mouse model. After bladder stones developed in vivo, they were harvested and separated into four developmental stages (sand, small, medium and large stone), based on their size. Data-dependent and data-independent acquisitions allowed deep profiling of stone proteomics. The proteomic signatures and pathways illustrated major changes as the stones grew. Stones initiate from a small nidus, grow outward, and show major enrichment in ribosomal proteins and factors related to coagulation and platelet degranulation, suggesting a major dysregulation in specific pathways that can be targeted for new therapeutic options.

Identifiants

pubmed: 35771811
doi: 10.1371/journal.pone.0250137
pii: PONE-D-21-10047
pmc: PMC9246204
doi:

Substances chimiques

Cystine 48TCX9A1VT

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0250137

Subventions

Organisme : NIA NIH HHS
ID : R01 AG068288
Pays : United States
Organisme : NIH HHS
ID : S10 OD016281
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Endourol. 1999 May;13(4):309-12
pubmed: 10405912
Mol Cell Proteomics. 2007 Sep;6(9):1638-55
pubmed: 17533153
J Am Soc Nephrol. 2002 Oct;13(10):2547-53
pubmed: 12239244
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
J Am Soc Mass Spectrom. 2016 Nov;27(11):1758-1771
pubmed: 27590315
J Am Soc Nephrol. 2017 Dec;28(12):3579-3589
pubmed: 28814511
Urolithiasis. 2021 Aug;49(4):281-290
pubmed: 33587148
Med Hypotheses. 1991 Dec;36(4):368-70
pubmed: 1809856
Nat Genet. 1994 Apr;6(4):420-5
pubmed: 8054986
PLoS One. 2014 Apr 22;9(4):e94816
pubmed: 24756028
Hum Genet. 1995 Jun;95(6):633-6
pubmed: 7789946
Sci Rep. 2017 Jun 8;7(1):3024
pubmed: 28596590
J Urol. 2018 Dec;200(6):1285-1289
pubmed: 30059686
Postgrad Med J. 2006 Dec;82(974):799-801
pubmed: 17148700
Am J Physiol Renal Physiol. 2007 Sep;293(3):F732-40
pubmed: 17596531
J Proteome Res. 2015 Jan 2;14(1):567-77
pubmed: 25365230
Methods Mol Biol. 2017;1550:223-233
pubmed: 28188533
Nat Commun. 2017 Aug 21;8(1):291
pubmed: 28827567
Mol Cell Proteomics. 2015 Sep;14(9):2405-19
pubmed: 25987414
Urol Clin North Am. 2007 Aug;34(3):295-313
pubmed: 17678981
Urology. 2012 Aug;80(2):260-6
pubmed: 22516363
Mol Cell Proteomics. 2015 May;14(5):1400-10
pubmed: 25724911
Urolithiasis. 2017 Feb;45(1):57-74
pubmed: 27913854
Am J Clin Dermatol. 2013 Jun;14(3):223-33
pubmed: 23605177
Mol Cell Proteomics. 2012 May;11(5):202-14
pubmed: 22454539
Toxicol Lett. 2012 Aug 3;212(3):307-14
pubmed: 22688180
Nephrol Dial Transplant. 2007 Jun;22(6):1537-46
pubmed: 17389622
J Transl Med. 2015 Mar 30;13:103
pubmed: 25888842
J Pediatr Urol. 2015 Aug;11(4):217.e1-6
pubmed: 26076823
Urol Res. 2009 Dec;37(6):323-9
pubmed: 19730843
Urology. 1997 Oct;50(4):508-11
pubmed: 9338723
Urol Clin North Am. 2013 Feb;40(1):1-12
pubmed: 23177630
BMJ Open. 2017 Jun 1;7(5):e014294
pubmed: 28576889
Urolithiasis. 2017 Aug;45(4):337-346
pubmed: 28314883
PLoS One. 2013 Jul 09;8(7):e68624
pubmed: 23874695
Urology. 2010 Oct;76(4):1017.e13-20
pubmed: 20709378
Semin Nephrol. 2008 Mar;28(2):181-91
pubmed: 18359399
Bioinformatics. 2010 Apr 1;26(7):966-8
pubmed: 20147306
Biomark Insights. 2016 Mar 16;11:41-8
pubmed: 26997865
J Proteome Res. 2007 Jun;6(6):2287-94
pubmed: 17488005
J Urol. 1999 Apr;161(4):1085-7
pubmed: 10081843
Urol Res. 1998;26(6):383-8
pubmed: 9879817

Auteurs

Jacob Rose (J)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Nathan Basisty (N)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Tiffany Zee (T)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Cameron Wehrfritz (C)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Neelanjan Bose (N)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Pierre-Yves Desprez (PY)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Pankaj Kapahi (P)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Marshall Stoller (M)

University of California San Francisco, San Francisco, CA, United States of America.

Birgit Schilling (B)

Buck Institute for Research on Aging, Novato, CA, United States of America.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH